Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Tirzepatide (marketed as Mounjaro for diabetes, used off-label for weight loss) produces weight reduction through dual GLP-1 and GIP receptor activationa mechanism stronger than single-agent GLP-1 drugs
In most cases yes
Depending on how well you tolerate the medication, your healthcare provider may gradually increase your dose every four weeks until you reach a maintenance dose level, which varies from person to person
With the right approach, you can still enjoy fast foodwithout sacrificing progress
This dose also demonstrated cardiovascular risk reduction in the SELECT trial
US$ 24.47
US$ 29.31
US$ 26.49
